Platform
Features
Pricing
1 follower
Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.
Industries
Headquarters
Employees
Links
Göran Forsberg
9 members
5 members
8 members
4 members
2 members
Immunome
2 followers
Artisanal Talent Group
10 followers
KTH Royal Institute of Technology
4 followers
Loopcraft
UtilizeCore
3 followers
Amgen
208 followers
Capricor Therapeutics
Elicio Therapeutics
FS
17 followers
JSW Energy Ltd
8 followers
Pyrme
7 followers
Explore companies